Abstract
Subconjunctival gentamicin was identified as the cause of conjunctival chemosis and capillary closure in a recent study conducted in this department. The gentamicin preparation used in the study contained preservatives. The current prospective study was set up to investigate the role of preservatives in the conjunctival toxicity of subconjunctival gentamicin. Seventy five patients undergoing cataract surgery were enrolled in the study. They were split into three groups of 25 each. Group A patients were given a subconjunctival injection of a preservative-free aqueous solution of gentamicin at the end of the cataract procedure. Group B patients were given a subconjunctival injection of gentamicin containing sodium metabisulphite and disodium edetate as preservatives at the end of the cataract procedure. Group C was the control group where patients were not given any subconjunctival injection. The incidence of severity of conjunctival chemosis were observed in the three groups. The difference between groups A and B patients who received preservative-free gentamicin and gentamicin with preservatives respectively was significant (p < 0.02).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berger R. E., Gomez L. S., Mallette L. E. Acute hypocalcemic effects of clinical contrast media injections. AJR Am J Roentgenol. 1982 Feb;138(2):283–288. doi: 10.2214/ajr.138.2.283. [DOI] [PubMed] [Google Scholar]
- Caulfield J. B., Zir L., Harthorne J. W. Blood calcium levels in the presence of arteriographic contrast material. Circulation. 1975 Jul;52(1):119–123. doi: 10.1161/01.cir.52.1.119. [DOI] [PubMed] [Google Scholar]
- D'Amico D. J., Kenyon K. R., Albert D. M., Hanninen L. Lipid inclusions in human ocular tissues in vitro induced by aminoglycoside antibiotics. Birth Defects Orig Artic Ser. 1982;18(6):411–420. [PubMed] [Google Scholar]
- D'Amico D. J., Libert J., Kenyon K. R., Hanninen L. A., Caspers-Velu L. Retinal toxicity of intravitreal gentamicin. An electron microscopic study. Invest Ophthalmol Vis Sci. 1984 May;25(5):564–572. [PubMed] [Google Scholar]
- Davison C. R., Tuft S. J., Dart J. K. Conjunctival necrosis after administration of topical fortified aminoglycosides. Am J Ophthalmol. 1991 Jun 15;111(6):690–693. doi: 10.1016/s0002-9394(14)76771-6. [DOI] [PubMed] [Google Scholar]
- Goulstine D. B., Marmion V. J. Subconjunctival gentamicin. Br J Ophthalmol. 1971 Jul;55(7):478–480. doi: 10.1136/bjo.55.7.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hull D. S., Chemotti M. T., Edelhauser H. F., Van Horn D. L., Hyndiuk R. A. Effect of epinephrine on the corneal edothelium. Am J Ophthalmol. 1975 Feb;79(2):245–250. doi: 10.1016/0002-9394(75)90078-1. [DOI] [PubMed] [Google Scholar]
- Jenkins C. D., McDonnell P. J., Spalton D. J. Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery. Br J Ophthalmol. 1990 Dec;74(12):734–738. doi: 10.1136/bjo.74.12.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kosek J. C., Mazze R. I., Cousins M. J. Nephrotoxicity of gentamicin. Lab Invest. 1974 Jan;30(1):48–57. [PubMed] [Google Scholar]
- Libert J., Ketelbant-Balasse P. E., Van Hoof F., Aubert-Tulkens G., Tulkens P. Cellular toxicity of gentamicin. Am J Ophthalmol. 1979 Mar;87(3):405–411. doi: 10.1016/0002-9394(79)90085-0. [DOI] [PubMed] [Google Scholar]
- Pande M. Postoperative conjunctival chemosis in cataract surgery caused by subconjunctival gentamicin injection. Br J Ophthalmol. 1991 Nov;75(11):660–662. doi: 10.1136/bjo.75.11.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sasamoto K., Akagi Y., Kodama Y., Itoi M. Corneal endothelial changes caused by ophthalmic drugs. Cornea. 1984;3(1):37–41. [PubMed] [Google Scholar]
- Wilson F. M., 2nd Adverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study. Trans Am Ophthalmol Soc. 1983;81:854–965. [PMC free article] [PubMed] [Google Scholar]